17 July 2013
Medical Startup Neural Analytics closed first seed round on $250K. The company, founded by graduates of MBA UCLA Anderson School of Management, created algorithm based on ten years investigation, conducted by Medical Center of UCLA University, use of which allows to the accuracy 92% measure increased intracranial pressure by noninvasive method.
Finances have been provided by representatives of the Funds Detonate Ventures and Venture Angels, and also private investor – doctor from Hong-Kong. Leading investor became a partner of SKOLKOVO Investors Club – the company Bears Investment Group.
Ultrasound device measures speed of cerebral blood flow, and, placing it on comparative data of conducted medicine investigations, during several seconds can define whether a human is addicted to increased intracranial pressure and needs additional therapy.
Merry Christmas and Happy New Year!
28 December 2024
NovaMedica team in the TOP 100 INFLUENTIAL PEOPLE IN THE PHARMACEUTICAL BUSINESS 2024
28 November 2024
05 November 2024
2024 drug approvals: Small companies loom large with several key FDA nods
13 January 2025
Special Regulations for Foreign-Packaged Medicines Extended Until the End of 2025
13 January 2025
Russia Begins Production of Terbium-161 Isotope for Cancer Therapy
10 January 2025
FMBA has begun clinical trials of a vaccine against five serotypes of meningococcus
10 January 2025